Health monitoring programme proposal published:
This article was originally published in Clinica
The European Commission's amended proposal for a European Parliament and Council Decision adopting a health monitoring programme was published in the Official Journal of the European Communities on July 24th. The programme is part of the public health action framework programme.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.